Cardiovascular diseases and osteoporosis: What is common?

Cardiovascular diseases and osteoporosis: What is common?

The review analyzes the possible effect of cardiac drugs on the course of osteoporosis (OP). The fact that atherosclerosis and OP share the mechanisms of development, among which the enhanced activity of the sympathetic part of the autonomic nervous system and endothelial dysfunction are most import...

Full description

Bibliographic Details
Main Authors:	I L Fedorchenko, D V Nebieridze, A S Safarian, I A Skripnikova, K E Sobchenko
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2014-05-01
Series:	Терапевтический архив
Subjects:	microcirculation sympathetic activity endothelial dysfunction bone mineral density nebivolol osteoporosis
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31540

Similar Items

THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION
by: I. L. Tepoyan, et al.
Published: (2015-09-01)

Effects of nebivolol on artery hypertension--multicentre study Bosnia and Herzegovina
by: Zumreta Kušljugić, et al.
Published: (2005-02-01)

Endothelium dysfunction at arterial hypertension: focus on nebivolol
by: Nikolay Aleksandrovich Vaulin
Published: (2009-03-01)

Premenopausal osteoporosis
by: Marilyn Lee Cheng, et al.
Published: (2013-01-01)

Genetics of Osteoporosis
by: Şengül Tural, et al.
Published: (2011-12-01)

Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength
by: I. A. Skripnikova, et al.
Published: (2019-03-01)

Progress of osteoporosis: stratification of fracture risk
by: Oksana A. Nikitinskaya, et al.
Published: (2018-04-01)

Increased risk of osteoporosis in depressive patients with erectile dysfunction: A cross-sectional study from Malaysia
by: Abdul Rahman Fata Nahas, et al.
Published: (2017-01-01)

Male Osteoporosis in Our Population
by: Seher Kocaoğlu, et al.
Published: (2002-12-01)

EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS
by: I. A. Skripnikova, et al.
Published: (2015-12-01)

Latest findings in the field of osteoporosis: Ukrainian-Portuguese dialogue
by: N. Kuprinenko
Published: (2016-04-01)

Use of pamidronate for osteoporosis treatment in public health care in Brazil
by: Leila Bianchet Zanatta, et al.

Osteoporosis en mujeres premenopáusicas con bocio tóxico difuso Osteoporosis in premenopausal women with toxic diffuse goiter
by: Adalberto Infante Amorós, et al.
Published: (2006-12-01)

Nebivolol Increases Nitric Oxide Synthase via β<sub>3</sub> Adrenergic Receptor in Endothelial Cells Following Exposure to Plasma from Preeclamptic Patients
by: Thaina Omia Bueno-Pereira, et al.
Published: (2022-03-01)

Is osteoporosis an autoimmune mediated disorder?
by: Rosebella A. Iseme, et al.
Published: (2017-12-01)

Treatment of osteoporosis with teriparatide: The Slovenian experience
by: Kocjan Tomaz, et al.
Published: (2021-10-01)

Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-Osteoporotic Drugs (Part II). The Effect of Antiosteoporotic Drugs on the Vascular Wall State
by: I. A. Skripnikova, et al.
Published: (2019-07-01)

Schizophrenia and osteoporosis
by: Nikolić Tatjana, et al.
Published: (2018-01-01)

Profile of romosozumab and its potential in the management of osteoporosis
by: Lim SY, et al.
Published: (2017-04-01)

Impressive results of teriparatide treatment of postgastrectomy osteoporosis
by: Tatjana Bačun, et al.
Published: (2011-08-01)

Herbal Treatment for Osteoporosis: A Current Review
by: Ping-Chung Leung, et al.
Published: (2013-04-01)

Correction: Efficacy of Denosumab in the Treatment of Postmenopausal Osteoporosis: One-year Follow-up, Single Center Study
by: İsmail Tunçekin, et al.
Published: (2023-12-01)

Relationship between parameters of subclinical atherosclerosis and osteoporosis and their prognostic significance: data from the prospective studies
by: I. A. Skripnikova, et al.
Published: (2023-11-01)

Dietary Calcium Intake and Osteoporosis Risk in Arab Adults
by: Nasser M. Al-Daghri, et al.
Published: (2023-06-01)

Denosumab – a new medication in the treatment of postmenopausal osteoporosis
by: Radosław Słopień, et al.
Published: (2017-10-01)

Examination of Oxidative Stress Markers in Women with Postmenopausal Osteoporosis
by: Okan Dikker, et al.
Published: (2018-04-01)

Experience in using Prolia in patients with postmenopausal osteoporosis in clinical practice
by: I A Skripnikova, et al.
Published: (2017-12-01)

The Role of Trace Elements and Minerals in Osteoporosis: A Review of Epidemiological and Laboratory Findings
by: Anatoly V. Skalny, et al.
Published: (2023-06-01)

Diabetes Mellitus and Osteoporosis
by: Alev Eroğlu Altınova, et al.
Published: (2011-12-01)

SYSTEMIC SCLEROSIS AND OSTEOPOROSIS
by: R. T. Alekperov, et al.
Published: (2016-02-01)

ASSOCIATION OF SERUM P1NP (N-TERMINAL PROPEPTIDE OF TYPE1 COLLAGEN) AND BONE MINERAL DENSITY (BMD) IN OSTEOPOROSIS
by: Afshan Iftikhar, et al.
Published: (2018-04-01)

A Neglected Risk Factor in Patients with Osteoporosis: Cigarette Smoking
by: Özlem Taşoğlu, et al.
Published: (2011-08-01)

Nebivolol for treatment patients with arterial hypertension
by: O M Mikheeva, et al.
Published: (2014-09-01)

ASSOCIATION OF INTERLEUKIN-1β GENE POLYMORPHISM WITH POSTMENOPAUSAL OSTEOPOROSIS IN WOMEN IN THE RUSSIAN POPULATION
by: M. Yu. Krylov, et al.
Published: (2015-10-01)

EVALUATION OF THE EFFICIENCY OF ANTIRESORPTIVE THERAPY FOR OSTEOPOROSIS IN MULTIPAROUS WOMEN
by: I.G. MUKHAMEDOVA, et al.
Published: (2019-06-01)

Heel ultrasound scan in detecting osteoporosis in low trauma fracture patients
by: Faiz R. Hashmi, et al.
Published: (2016-06-01)

Osteoporosis Due to Cadmium Exposure
by: Mustafa Turgut Yıldızgören, et al.
Published: (2014-04-01)

Postmenopausal osteoporosis: Our experience
by: R N Mehrotra, et al.
Published: (2012-01-01)

The Relationship Between Laboratory Findings and Bone Mineral Density in Patients with Osteoporosis
by: Gülseren Dost Sürücü, et al.
Published: (2022-08-01)

Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents
by: Ji-Hee Yoon, et al.
Published: (2021-06-01)